Madrigal Pharmaceuticals Inc
MDGL
NASDAQ
Biotechnology
$507.56
USD
+0.19 (+0.04%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $11.73B
Volume 234.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | $16.64B | - | +355.2% | - | |
BMRN | BioMarin Pharmaceutical Inc | $13.23B | 181.37 | +11.2% | - | |
EXEL | Exelixis Inc | $13.12B | 15.24 | +9.2% | - | |
ARWR | Arrowhead Pharmaceuticals Inc | $12.46B | - | +16.9% | - | |
MDGL | Madrigal Pharmaceuticals Inc | $11.91B | - | +149.0% | - | |
SMMT | Summit Therapeutics Inc | $11.86B | - | - | - | |
HALO | Halozyme Therapeutics Inc | $11.78B | 28.48 | +41.1% | - | |
PRAX | Praxis Precision Medicines Inc | $10.25B | - | - | - | |
APGE | Apogee Therapeutics Inc | $10.18B | - | - | - | |
KRYS | Krystal Biotech Inc | $9.73B | 40.29 | +22.6% | - |
Top Peer by Growth
BridgeBio Pharma Inc
+355.2% YoY Revenue
Lowest P/E Ratio
Exelixis Inc
14.54x P/E
Best 1-Year Return
Praxis Precision Medicines Inc
+697.2% Return